Vineet Laboratories Limited (NSE:VINEETLAB)
India · Delayed Price · Currency is INR 37.37
-0.13 (-0.35%)
Sep 4, 2026, 3:29 PM IST
Vineet Laboratories Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 594.01 | 749.95 | 1,506 | 2,123 | 1,912 |
Other Revenue | 1.04 | 19.58 | 3.73 | - | - |
| 595.05 | 769.53 | 1,510 | 2,123 | 1,912 | |
Revenue Growth | -22.67% | -49.03% | -28.89% | 11.05% | -21.48% |
Cost of Revenue | 386.08 | 730.76 | 1,181 | 1,761 | 1,497 |
Gross Profit | 208.97 | 38.77 | 329.08 | 361.93 | 414.24 |
Selling, General & Admin | 40.96 | 53.75 | 64.83 | 60.71 | 58.31 |
Other Operating Expenses | 82.18 | 128.27 | 188.52 | 227.99 | 224.31 |
Operating Expenses | 147.29 | 207.04 | 278.54 | 312.43 | 302.78 |
Operating Income | 61.68 | -168.27 | 50.54 | 49.5 | 111.46 |
Interest Expense | -48.85 | -38.31 | -38.49 | -26.58 | -14.89 |
Interest & Investment Income | - | - | 0.35 | 1.23 | 1.62 |
Currency Exchange Gain (Loss) | - | 0.04 | 0.07 | 3.37 | 0.92 |
Other Non Operating Income (Expenses) | -0 | -1.47 | -9.32 | -7.22 | -5.65 |
EBT Excluding Unusual Items | 12.83 | -208 | 3.15 | 20.3 | 93.46 |
Gain (Loss) on Sale of Investments | - | 0.25 | 0.48 | - | - |
Pretax Income | 12.83 | -207.76 | 3.63 | 20.3 | 93.46 |
Income Tax Expense | 1.72 | -5.85 | -6.64 | 7.77 | 27.07 |
Net Income | 11.11 | -201.91 | 10.27 | 12.53 | 66.39 |
Net Income to Common | 11.11 | -201.91 | 10.27 | 12.53 | 66.39 |
Net Income Growth | - | - | -18.00% | -81.13% | 272.89% |
Shares Outstanding (Basic) | 11 | 9 | 9 | 9 | 9 |
Shares Outstanding (Diluted) | 11 | 9 | 9 | 9 | 9 |
Shares Change | 20.49% | - | - | - | - |
EPS (Basic) | 1.00 | -21.90 | 1.11 | 1.36 | 7.20 |
EPS (Diluted) | 1.00 | -21.90 | 1.11 | 1.36 | 7.20 |
EPS Growth | - | - | -18.30% | -81.13% | 272.84% |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | -132.29 | 104.46 | -94 | -172.5 | 76.32 |
Free Cash Flow Per Share | -11.91 | 11.33 | -10.20 | -18.71 | 8.28 |
Dividend Per Share | - | - | - | - | 1.000 |
Dividend Growth | - | - | - | - | - |
Gross Margin | 35.12% | 5.04% | 21.80% | 17.05% | 21.67% |
Operating Margin | 10.37% | -21.87% | 3.35% | 2.33% | 5.83% |
Profit Margin | 1.87% | -26.24% | 0.68% | 0.59% | 3.47% |
Free Cash Flow Margin | -22.23% | 13.57% | -6.23% | -8.13% | 3.99% |
EBITDA | 85.83 | -143.25 | 75.73 | 73.23 | 131.62 |
EBITDA Margin | 14.42% | -18.62% | 5.02% | 3.45% | 6.88% |
D&A For EBITDA | 24.15 | 25.02 | 25.19 | 23.73 | 20.16 |
EBIT | 61.68 | -168.27 | 50.54 | 49.5 | 111.46 |
EBIT Margin | 10.37% | -21.87% | 3.35% | 2.33% | 5.83% |
Effective Tax Rate | 13.40% | - | - | 38.30% | 28.97% |
Revenue as Reported | 595.05 | 769.82 | 1,511 | 2,124 | 1,915 |
Advertising Expenses | - | 0.05 | 0.59 | 0.5 | 0.75 |